Living with systemic sclerosis? Let’s join together to explore a potential new investigational treatment.

Systemic sclerosis is a rare, chronic autoimmune disease. With systemic sclerosis, excess collagen accumulates between cells. This can cause problems around the body, including on the skin, between joints, around the lungs, digestive tract, heart, and kidneys. Currently, there is no approved general medication for systemic sclerosis.

Jacksonville Center for Clinical Research is conducting a study that will evaluate the effectiveness and safety of an investigational once-weekly injectable medication for systemic sclerosis.

You may be eligible if you:

• Are 18-70 years old
• Weigh ≤ 319.7 lbs
• Have systemic sclerosis

For the duration of the study, participants may remain on any of the following immunosuppressant medications (if applicable):  hydroxychloroquine, MMF or MPA, methotrexate, azathioprine, tacrolimus, and low-dose oral glucocorticoids.

There are additional criteria to meet to qualify for this study. Volunteers who qualify for our study will receive study-related medication and medical exams at no cost, along with a stipend for time and travel. No health insurance is required to participate.

For more information call

(904) 379-0742